ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274 | -44.1% | 45,115 | -28.5% | 0.00% | – |
| Q2 2023 | $490 | +44.5% | 63,064 | +6.3% | 0.00% | – |
| Q1 2023 | $339 | -3.1% | 59,339 | 0.0% | 0.00% | – |
| Q4 2022 | $350 | -99.8% | 59,339 | 0.0% | 0.00% | – |
| Q3 2022 | $191,000 | -18.7% | 59,339 | +13.2% | 0.00% | – |
| Q2 2022 | $235,000 | -30.9% | 52,439 | -17.6% | 0.00% | – |
| Q1 2022 | $340,000 | -51.6% | 63,660 | +33.3% | 0.00% | – |
| Q4 2021 | $702,000 | – | 47,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |